Skip to main content
Jan Cerny, MD, Oncology, Worcester, MA, UMass Memorial Medical Center

JanCernyMDPhD, FACP

Oncology Worcester, MA

Associate Professor, Medicine, University Massachusetts Medical School

Dr. Cerny is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cerny's full profile

Already have an account?

  • Office

    55 Lake Ave N
    Dept Of Medicine, Hematology/Oncology, Bone Marrow Transplant
    Worcester, MA 01655
    Phone+1 774-442-3903
    Fax+1 774-442-6715
  • Is this information wrong?

Summary

  • Dr. Jan Cerny is a hematologist/oncologist practicing in Worcester, MA and is affiliated with UMass Memorial Medical Center. He received his medical degree from Charles University Faculty of Medicine and has been in practice 18 years. He specializes in hematologic oncology and is experienced in leukemia, myeloid malignancies, myelodysplasia, myelofibrosis, lymphoma and multiple myeloma.He performs bone marrow transplants as well.

Education & Training

  • UMass Chan Medical School
    UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 2006 - 2009
  • UMass Chan Medical School
    UMass Chan Medical SchoolResidency, Internal Medicine, 2003 - 2006
  • Karlovy University FOM
    Karlovy University FOMClass of 1999

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2006 - 2024
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle and Connolly, 2017
  • Regional Top Doctor Castle Connoly, 2015
  • Regional Top Doctor Castle Connolly, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Books/Book Chapters

Lectures

  • High Dose Mitoxantrone Based “5+1” Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Hematopoeitic Cell Transplant - Comorbidity Index (HCT-CI) Score Is a Useful Tool for Predicting Induction Mortality and Overall Survival in Newly Diagnosed Acute Myel... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Professional Memberships

Other Languages

  • Czech

Hospital Affiliations